Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer
Launched by M.D. ANDERSON CANCER CENTER · Apr 11, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a Mediterranean diet might help men with prostate cancer who are treated at LBJ Hospital in Harris County, Texas. The Mediterranean diet is rich in fruits, vegetables, whole grains, and healthy fats, and the researchers want to see if following this diet can be beneficial for men who are Hispanic and/or Black/African American and have been diagnosed with localized prostate cancer within the past year or are under active surveillance.
To join the study, participants need to have a confirmed diagnosis of prostate cancer and be patients at LBJ Hospital. They should be between the ages of 65 and 74, and they must be willing to try changing their diet to follow the Mediterranean guidelines. Participants will keep track of their food intake and take part in study activities, but they should not have any food allergies that would prevent them from following the diet. This trial is not yet recruiting participants, but it aims to help improve dietary options and health outcomes for men facing prostate cancer.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Histologically confirmed adenocarcinoma of the prostate that is localized based on metastatic workup ordered by the treating physician (which may include CT scan, bone scan, MRI and/or other imaging). Note that metastatic workup is not required for enrollment.
- • Diagnosis within 12 months prior to enrollment OR
- • Currently managed on active surveillance, with initial biopsy being \<5 years from date of enrollment
- • Self-identified Hispanic and/or Black/African American
- • Patient at LBJ Hospital
- Exclusion Criteria:
- • Special dietary requirements such that patient is unwilling to attempt dietary change
- • Inability to complete a food record
- • Unwillingness to participate in study activities
- • Inability to keep appointments
- • Food allergy prohibitive of a Mediterranean diet, i.e. nuts allergy
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Justin Gregg, MD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported